(1)
Nurseta, T.; Herliawati, P. A.; Harnandari, D. E. P.; Handono, K.; Irwanto, Y.; Sutrisno, S. Risk of Malignancy Index 3 (RMI3) Performance As a Predictor Advanced Stage Epithelial Ovarian Carcinoma Used for NACT: Perfoma Risk of Malignancy Index 3 (RMI3) Sebagai Prediktor Karsinoma Ovarium Epithelial Stadium Lanjut Untuk Pertimbangan Pemberian NACT. Indones J Obstet Gynecol 2022, 10, 42-48.